Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Jun 21, 2010 12:31pm
280 Views
Post# 17207213

Interesting

InterestingAfter watching the first two trades of the day hit the tape, it shows me that there is currently no one watching this company. Volume is building on the bid side and it was a good time for anyone holding a larger position to cash out but no one took the bait. The share price is dependent on news and when we are in this slow period, we tend to drift down at the mercy of small sell orders at the market.
     This interest on the bid is enough to push us up 10-15% today once it is seen and it will be ashame if we get a few small, end of the day sell orders. The bid is already moving up(which we will se get hit with small sales)  so we will just have to see what takes place.

     Remember that we will hear about Gen-probe submitting to the FDA in the next couple months. Still enough to get us above $2.00.
Bullboard Posts